[Evolution of strategies for selecting dopaminergic therapy in Parkinson's disease].
Over the past five decades, strategies for dopaminergic therapy in Parkinson's disease (PD) have evolved significantly. Historically treatments aimed to reduce parkinsonism symptoms. Later, the focus shifted to preventing motor fluctuations and dyskinesias, leading clinicians to delay levodopa initiation. As knowledge...